AFT updates earnings guidance

Apr 4, 2021 | Latest News

1.4.21 AFT Pharmaceuticals has negatively revised its guidance on its financial results for the year to 31 March 2021 following a number of COVID-19 related delays to licensing negotiations and disruptions to the company’s global supply and distribution networks. AFT expects revenue for the 2021 financial year to be around $110 million, representing an uplift […]

You need an active membership to keep reading

either log in via the form below or click here to subscribe

If you have recently subscribed and selected to pay by bank transfer our admin team will activate your membership once payment has cleared

[adrotate banner="4"]

AFT updates earnings guidance

You need an active membership to keep reading

either log in via the form below or click here to subscribe

Your Advertisement Here

Your Advertisement Here